Increased intrathecal high-avidity anti-tau antibodies in patients with multiple sclerosis

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Fialová, Lenka ^a   Bartos, Ales ^b,c   Švarcová, Jana ^c,d   Malbohan, Ivan ^a,d  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

^d CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; TAU PROTEIN; ANTIIDIOTYPIC ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; BLOOD SAMPLING; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID LEVEL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; ANTIBODY AFFINITY; BLOOD; CASE CONTROL STUDY; CEREBROSPINAL FLUID; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; SPINAL CORD;

ADULT; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODY AFFINITY; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; SPINAL CORD; TAU PROTEINS;

EID: 82255195405     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027476     Document Type: Article

References (36)

1. McFarland HF, Martin R, (2007) Multiple sclerosis: a complicated picture of autoimmunity. Nat Immunol 8: 913-919.
2. Huizinga R, Linington C, Amor S, (2008) Resistance is futile: antineuronal autoimmunity in multiple sclerosis. Trends Immunol 29: 54-60.
3. Brettschneider J, Maier M, Arda S, Claus A, Sussmuth SD, et al. (2005) Tau protein level in cerebrospinal fluid is increased in patients with early multiple sclerosis. Mult Scler 11: 261-265.
4. Semra YK, Seidi OA, Sharief MK, (2002) Heightened intrathecal release of axonal cytoskeletal proteins in multiple sclerosis is associated with progressive disease and clinical disability. J Neuroimmunol 122: 132-139.
5. Terzi M, Birinci A, Cetinkaya E, Onar MK, (2007) Cerebrospinal fluid total tau protein levels in patients with multiple sclerosis. Acta Neurol Scand 115: 325-330.
6. Brettschneider J, Petzold A, Junker A, Tumani H, (2006) Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis. Mult Scler 12: 143-148.
7. Niebroj-Dobosz I, Dziewulska D, Janik P, (2006) Auto-antibodies against proteins of spinal cord cells in cerebrospinal fluid of patients with amyotrophic lateral sclerosis (ALS). Folia Neuropathol 44: 191-196.
8. Silber E, Semra YK, Gregson NA, Sharief MK, (2002) Patients with progressive multiple sclerosis have elevated antibodies to neurofilament subunit. Neurology 58: 1372-1381.
9. Fialova L, Bartos A, Soukupova J, Svarcova J, Ridzon P, et al. (2009) Synergy of serum and cerebrospinal fluid antibodies against axonal cytoskeletal proteins in patients with different neurological diseases. Folia Biol (Praha) 55: 23-26.
10. Terryberry JW, Thor G, Peter JB, (1998) Autoantibodies in neurodegenerative diseases: antigen-specific frequencies and intrathecal analysis. Neurobiol Aging 19: 205-216.
11. Ehling R, Lutterotti A, Wanschitz J, Khalil M, Gneiss C, et al. (2004) Increased frequencies of serum antibodies to neurofilament light in patients with primary chronic progressive multiple sclerosis. Mult Scler 10: 601-606.
12. Bartos A, Fialova L, Soukupova J, Kukal J, Malbohan I, et al. (2007) Antibodies against light neurofilaments in multiple sclerosis patients. Acta Neurol Scand 116: 100-107.
13. Bartos A, Fialova L, Soukupova J, Kukal J, Malbohan I, et al. (2007) Elevated intrathecal antibodies against the medium neurofilament subunit in multiple sclerosis. J Neurol 254: 20-25.
14. Svarcova J, Fialova L, Bartos A, Steinbachova M, Malbohan I, (2008) Cerebrospinal fluid antibodies to tubulin are elevated in the patients with multiple sclerosis. Eur J Neurol 15: 1173-1179.
15. Cleveland DW, Hwo SY, Kirschner MW, (1977) Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin. J Mol Biol 116: 207-225.
16. Binder LI, Frankfurter A, Rebhun LI, (1985) The distribution of tau in the mammalian central nervous system. J Cell Biol 101: 1371-1378.
17. Drubin DG, Kirschner MW, (1986) Tau protein function in living cells. J Cell Biol 103: 2739-2746.
18. Rosenmann H, Meiner Z, Geylis V, Abramsky O, Steinitz M, (2006) Detection of circulating antibodies against tau protein in its unphosphorylated and in its neurofibrillary tangles-related phosphorylated state in Alzheimer's disease and healthy subjects. Neurosci Lett 410: 90-93.
19. Lublin FD, Reingold SC, (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 46: 907-911.
20. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, et al. (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50: 121-127.
21. Kurtzke JF, (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33: 1444-1452.
22. Matheus S, Deparis X, Labeau B, Lelarge J, Morvan J, et al. (2005) Discrimination between primary and secondary dengue virus infection by an immunoglobulin G avidity test using a single acute-phase serum sample. J Clin Microbiol 43: 2793-2797.
23. Himmler A, Drechsel D, Kirschner MW, Martin DW Jr, (1989) Tau consists of a set of proteins with repeated C-terminal microtubule-binding domains and variable N-terminal domains. Mol Cell Biol 9: 1381-1388.
24. Narita M, Yamada S, Matsuzono Y, Itakura O, Togashi T, et al. (1996) Immunoglobulin G avidity testing in serum and cerebrospinal fluid for analysis of measles virus infection. Clin Diagn Lab Immunol 3: 211-215.
25. Flori P, Tardy L, Patural H, Bellete B, Varlet MN, et al. (2004) Reliability of immunoglobulin G antitoxoplasma avidity test and effects of treatment on avidity indexes of infants and pregnant women. Clin Diagn Lab Immunol 11: 669-674.
26. Hedman K, Hietala J, Tiilikainen A, Hartikainen-Sorri AL, Raiha K, et al. (1989) Maturation of immunoglobulin G avidity after rubella vaccination studied by an enzyme linked immunosorbent assay (avidity-ELISA) and by haemolysis typing. J Med Virol 27: 293-298.
27. Cucnik S, Kveder T, Krizaj I, Rozman B, Bozic B, (2004) High avidity anti-beta 2-glycoprotein I antibodies in patients with antiphospholipid syndrome. Ann Rheum Dis 63: 1478-1482.
28. Cui Z, Wang HY, Zhao MH, (2006) Natural autoantibodies against glomerular basement membrane exist in normal human sera. Kidney Int 69: 894-899.
29. Milosevic-Jovcic N, Ciric D, Hajdukovic-Dragojlovic L, Mircetic V, (2004) Differences in the relationship of specificity to titre and functional affinity between circulating Ga- and pan-reactive IgM rheumatoid factors in rheumatoid arthritis. Rheumatology (Oxford) 43: 1190-1193.
30. Villalta D, Romelli PB, Savina C, Bizzaro N, Tozzoli R, et al. (2003) Anti-dsDNA antibody avidity determination by a simple reliable ELISA method for SLE diagnosis and monitoring. Lupus 12: 31-36.
31. Racke MK, (2008) The role of B cells in multiple sclerosis: rationale for B-cell-targeted therapies. Curr Opin Neurol 21 (Suppl 1): S9-S18.
32. Rosenmann H, Grigoriadis N, Karussis D, Boimel M, Touloumi O, et al. (2006) Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein. Arch Neurol 63: 1459-1467.
33. Graus F, Saiz A, Dalmau J, (2010) Antibodies and neuronal autoimmune disorders of the CNS. J Neurol 257: 509-517.
34. Zamecnik J, Cerny R, Bartos A, Jerabek J, Bojar M, (2004) Paraneoplastic opsoclonus-myoclonus syndrome associated with malignant fibrous histiocytoma: neuropathological findings. Cesk Patol 40: 63-67.
35. Huizinga R, Heijmans N, Schubert P, Gschmeissner S, t Hart BA, et al. (2007) Immunization with neurofilament light protein induces spastic paresis and axonal degeneration in Biozzi ABH mice. J Neuropathol Exp Neurol 66: 295-304.
36. Bartos A, Pitha J, (2003) Opsoclonus-myoclonus-dysequilibrium syndrome: cytological and immunological dynamics in the serial cerebrospinal fluid in two patients. J Neurol 250: 1420-1425.